Skopos Labs, Inc. Omnicell, Inc Transaction History
Skopos Labs, Inc.
- $497 Million
- Q2 2025
A detailed history of Skopos Labs, Inc. transactions in Omnicell, Inc stock. As of the latest transaction made, Skopos Labs, Inc. holds 76 shares of OMCL stock, worth $2,395. This represents 0.0% of its overall portfolio holdings.
Number of Shares
76
Previous 76
-0.0%
Holding current value
$2,395
Previous $2,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding OMCL
# of Institutions
280Shares Held
45.5MCall Options Held
68KPut Options Held
45.3K-
Black Rock Inc. New York, NY8.18MShares$258 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.64MShares$178 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.17MShares$68.3 Million0.02% of portfolio
-
State Street Corp Boston, MA2.17MShares$68.3 Million0.0% of portfolio
-
Lazard Asset Management LLC New York, NY1.65MShares$51.9 Million0.1% of portfolio
About OMNICELL, Inc
- Ticker OMCL
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 44,288,800
- Market Cap $1.4B
- Description
- Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensi...